Role of endothelial nitric oxide synthase in aggravation of indomethacin-induced gastric damage in adjuvant arthritic rats

Journal of Physiology and Pharmacology

Volumn 60, Issue 4, 2009, Pages 147-155

  Kato, Shinichi ^a   Ohkawa, F ^a   Ito, Y ^a   Amagase, K ^a   Takeuchi, K ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Adjuvant arthritis; Endothelial nitric oxide synthase; Indomethacin induced gastric damage; Inducible nitric oxide synthase; Nitric oxide

Indexed keywords

AMINOGUANIDINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; NONHUMAN; PROTEIN EXPRESSION; RAT; STOMACH INJURY; STOMACH MUCOSA; ULCEROGENESIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE; INDOMETHACIN; MALE; NITRATES; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; PROTEIN MULTIMERIZATION; RATS; SEVERITY OF ILLNESS INDEX; STOMACH DISEASES; SULFHYDRYL COMPOUNDS;

EID: 75749129892     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 1971; 231: 232-235.
2. Whittle BJR. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981; 80: 94-98.
3. Kato S, Tanaka A, Kunikata T, Nishijima M, Takeuchi K. Changes in gastric mucosal ulcerogenic responses in rats with adjuvant arthritis: role of nitric oxide. Aliment Pharmacol Ther 1999; 13: 833-840.
4. Kato S, Suzuki K, Ukawa H, Komoike Y, Takeuchi K. Low gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in rats with cirrhosis and arthritis. Dig Dis Sci 2001; 46: 1690-1699.
5. Kato S, Ogawa Y, Kanatsu K, et al. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis. J Pharmacol Exp Ther 2002; 303: 503-509.
6. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
7. Nathan C. Nitric oxide as a secretory product of mammalian cell. FASEB J 1992; 6: 3051-3064.
8. Lopez-Belmonte J, Whittle BJR, Moncada S. The action of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J Pharmacol 1993; 108: 73-78.
9. Grisham MB, Specian RD, Zimmerman TE. Effect of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis. J Pharmacol Exp Ther 1994; 271: 1114-1121.
10. Whittle BJR, Laszlo F, Evans SM, Moncada S. Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Br J Pharmacol 1995; 116: 2286-2290.
11. Mourelle M, Vllaseca J, Guarner F, Salas A, Malagelada JR. Toxic dilation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase. Am J Physiol 1996; 270: G425-430.
12. Yasuhiro T, Konaka A, Ukawa H, Kato S, Takeuchi K. Role of nitric oxide in pathogenesis of gastric mucosal damage induced by compound 48/80 in rats. J Physiol (Paris) 1997; 91: 131-138.
13. Konaka A, Nishijima M, Tanaka A, Kunikata T, Kato S, Takeuchi K. Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats. J Physiol Pharmacol 1999; 50: 25-38.
14. Rees DD, Palmer RMJ, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol 1990; 101: 746-752.
15. Laszlo F, Whittle BJ. Actions of isoform-selective and nonselective nitric oxide synthase inhibitors on endotoxininduced vascular leakage in rat colon. Eur J Pharmacol 1997; 334: 99-102.
16. Kobata A, Kotani T, Komatsu Y, Amagase K, Kato S, Takeuchi K. Dual action of nitric oxide in the pathogenesis of ischemia/reperfusion-induced mucosal injury in mouse stomach. Digestion 2007; 75: 188-197.
17. Sammut S, Park D, West A. Frontal cortical afferents facilitate striatal nitric oxide transmission in vivo via a NMDA receptor and neuronal NOS-dependent mechanism. J Neurochemistry 2007; 103: 1145-1156.
18. Kato S, Kawahara R, Yasuda M, Amagase K, Takeuchi K. Aggravation of cold-restraint stress-induced gastric lesions in adjuvant arthritic rats: pathogenic role of inducible and endothelial nitric oxide. J Pharmacol Sci 2009; Oct 31: epub ahead of print.
19. Kakoki M, Hirata Y, Hayakawa H, et al. Effects of tetrahydrobiopterin of endothelial dysfunction in rats with ischemic acute renal failure. J Am Soc Nephrol 2000; 11: 301-309.
20. Satoh M, Fujimoto S, Haruna Y, et al. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol 2005; 288: F1144-F1152.
21. Green LC, Tannebaum SR, Goldman P. Nitrate synthesis in the germ free and conventional rat. Science 1981; 212: 56-58.
22. Takeuchi K, Okada M, Niida H, Okabe S. Role of sulfhydryls in mucosal injury caused by ethanol: relation to microvascular permeability, gastric motility and cytoprotection. J Pharmacol Exp Ther 1989; 248: 836-841.
23. Forstermann U, Boissel JP, Kleinert H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 1998; 12: 773-790.
24. Ma L, Wallace JL. Endothelial nitric oxide synthase modulates gastric ulcer healing in rats. Am J Physiol 2000; 279: G341-G346.
25. Aoi Y, Terashima S, Ogura M, Nishio H, Kato S, Takeuchi K. Roles of nitric oxide (NO) and NO synthases in healing of dextran sulfate sodium-induced rat colitis. J Physiol Pharmacol 2008; 59: 315-336.
26. Stefanovic-Racic M, Meyers K, Meschter C, Coffey JW, Hoffman RA, Evans CH. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 1994; 37: 1062-1069.
27. Connor JR, Manning PT, Settle SL, et al. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitiric oxide synthase. Eur J Pharmacol 1995; 273:15-24.
28. Sakurai H, Kohsaka H, Liu MF, et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995; 96: 2357-2363.
29. Haruna Y, Morita Y, Komai N, et al. Endothelial dysfunction in rat adjuvant-induced arthritis: vascular superoxide production by NAD(P)H oxidase and uncoupling endothelial nitric oxide synthase. Arthritis Rheum 2006; 54: 1847-1855.
30. Tanaka A, Kunikata T, Mizoguchi H, Kato S, Takeuchi K. Dual action of nitric oxide in pathogenesis of indomethacininduced small intestinal ulceration in rats. J Physiol Pharmacol 1999; 50: 405-417.
31. Nathan C, Xie QW. Nitric oxide synthase: roles, tolls, and controls. Cell 1994; 78: 915-918.
32. Souza MH, Lemos HP, Oliveira RB, Cunha FQ. Gastric and granulocyte infiltration induced by indomethacin in tumor necrosis factor 1 (TNF-R1) on inducible nitric oxide (iNOS) deficient mice. Gut 2004; 53: 791-796.
33. Hausladen A, Privalle CT, Keng T, DeAngelo J, Stamler JS. Nitrosative stress: activation of the transcription factor OxyR. Cell 1996; 86: 719-729.
34. Hausladen A, Stamler JS. Nitrosative stress. Methods Enzymol 1999; 300: 719-729.
35. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624.
36. Palmer LA, Gaston B, Johns RA. Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redoxdependent effect of nitrogen oxides. Mol Pharmacol 2000; 58: 1197-1203.
37. Pacher P, Schulz R, Liaudet L, Szabo C. Nitrosative stress and pharmacological modulation of heart failure. Trends Pharmacol Sci 2005; 26: 302-310.
38. Lamarque D, Whittle BJR. Involvement of superoxide and xanthine oxidase in neutrophil-independent rat gastric damage induced by NO donors. Br J Pharmacol 1995; 116: 1843-1848.
39. Rachmilewitz D, Stamler JS, Karmeli F, et al. Peroxynitriteinduced rat colitis: a new model of colonic inflammation. Gastroenterology 2003; 105: 1681-1688.
40. Reed DJ. Glutathione: toxicological implications. Annu Rev Pharmacol Toxicol 1990; 30: 603-631.
41. Szabo S, Trier JS, Frankel PW. Sulfhydryl compounds may mediate gastric cytoprotection. Science 1981; 214: 200-204.
42. Dupuy D, Szabo S. Protection by metals against ethanolinduced gastric mucosal injury in the rat: comparative biochemical and pharmacological studies implicate protection sulfhydruls. Gastroenterology 1986; 91: 966-974.
43. Mutoh H, Hiraishi H, Ota S, et al. Protective role of intracellular glutathione against ethanol-induced damage in culture rat gastric mucosal cells. Gastroenterology 1990; 98: 1452-1459.
44. Wallace JL, Caliendo G, Santagada V, Cirino G, Fiorucci S. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfate-releasing dicrofenac derivative in the rat. Gastroenterology 2007; 132: 261-271.
45. Nossuli TO, Hayward R, Jensen D, Scalia R, Lefer AM. Mechanisms of cardioprotection by peroxynitrite in myocardial ischemia and reperfusion injury. Am J Physiol 1998; 272: H509-H519.
46. Laszlo F, Whittle BJR, Moncada S. Attenuation by nitrosothiol NO donors of acute intestinal microvascular dysfunction in the rat. Br J Pharmacol 1995; 115: 498-502.
47. Wu M, Pritchard KA Jr, Kaminski PM, Fayngersh RP, Hintze TH, Wolin MS. Involvement of nitric oxide and nitrosothiols in relaxation of pulmonary arteries to peroxynitrite. Am J Physiol 1994; 266: H2108-H2113.
48. Mayer B, Schrammel A, Klatt P, Koesling D, Schmidt K. Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylyl cyclase. Dependence on glutathione and possible role of Snitrosation. J Biol Chem 1995; 270: 17355-17360.
49. Kwiecien S, Pawlik NW, Brzozowski T, et al. Nitric oxide (NO)-releasing aspirin and (NO) donors in protection of gastric mucosa against stress. J Physiol Pharmacol 2008; 59(Suppl 2): 103-115.
50. Ueshima K, Takeuchi K, Okabe S. Effects of sulfhydrylrelated compounds on indomethacin-induced gastric lesions in rats: role of endogenous sulfhydryls in the pathogenesis. Jpn J Pharmacol 1992; 58: 157-165.
51. Wakulich CA, Tepperman BL. Role of glutathione in nitric oxide-mediated injury to rat gastric mucosal cells. Eur J Pharmacol 1997; 319: 333-341.
52. Stuehr D, Pou S, Rosen GM. Oxygen reduction by nitricoxide synthases. J Biol Chem 2001; 276: 14533-14536.
53. Landmesser U, Dikalov S, Price SR, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 2003; 111: 1201-1209.
54. Mollnau H, Wendt M, Szocs K, et al. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 2002; 90: E58-E65.
55. 2, cholera toxin and 8-bromocyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. Immunology 1995; 84: 446-452.
56. Yamane H, Sugimoto Y, Tanaka S, Ichikawa A. Prostaglandin E(2) receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils. Biochem Biophys Res Commun 2000; 278: 224-228.
57. 2 receptor subtype EP4 agonist attenuates cardiovascular depression in endotoxin shock by inhibiting inflammatory cytokines and nitric oxide production. Shock 2004; 22: 76-81.
58. Nishio H, Terashima S, Nakashima M, Aihara E, Takeuchi K. Involvement of prostaglandin E receptor EP3 subtype and prostacyclin IP receptor in decreased acid response in damaged stomach. J Physiol Pharmacol 2007; 58: 407-421.